Business development
EryDel is seeking for partnership or strategic alliances for the clinical development and/or commercialization of the therapies mediated by erythrocytes especially within the more mature applications:
• EryDex: Cystic Fibrosis
• EryDex: Inflammatory Bowel Diseases
• EryDex: other chronic inflammatory diseases
The interest is aimed at reaching one or more of the following objectives:
1. Reaching the market faster
2. Distribution and/or licensing agreements
3. New markets penetration (US, Japan…)
4. Develop other applications in the pipeline
5. Develop new customized applications
In case of interests and/or any request please contact us |
